WRF
BMY icon

Waddell & Reed Financial’s Bristol-Myers Squibb BMY Stock Holding History

Waddell & Reed Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50,000
Closed -$3.06M – 535
2017
Q4 		$3.06M Buy
+50,000
New +$3.13M 0.01% 489
2017
Q1 		– Sell
-50,000
Closed -$2.92M – 541
2016
Q4 		$2.92M Buy
+50,000
New +$2.73M 0.01% 534

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Waddell & Reed Financial's BMY Position: Q3 2019 in Review

Waddell & Reed Financial sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 8,119 shares — an estimated $368K sold.

Waddell & Reed Financial first reported a position in BMY in Q2 2013 and held it in 22 quarters. The position peaked at $900M in Q2 2015. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • Waddell & Reed Financial reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
  • Waddell & Reed Financial sold 8,119 Bristol-Myers Squibb shares in Q3 2019, an estimated $368K.
  • Waddell & Reed Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 22 quarters.
  • Waddell & Reed Financial's Bristol-Myers Squibb position peaked at $900M in Q2 2015.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Waddell & Reed Financial's 13F filing for Q3 2019, filed 14 Nov 2019.